Xylometazoline HCl/Dexpanthenol 0.5/50 mg/ml and 1.0/50 mg/ml ratiopharm, nasal spray, solution - public assessment report withdrawn application

This was an application procedure for a new combination containing two known active ingredients: xylometazoline hydrochloride and dexpanthenol. The MEB deems the claim - that the treatment duration is shortened by the addition of dexpanthenol and xylometazoine - not to have been demonstrated based on the literature that was submitted. The company withdrew the application before the end of the procedure.